Postoperative Analgesia, Adverse Events, and Patient Satisfaction After Hip Arthroplasty: Intermittent Catheter Bolus Versus Single-Injection Fascia Iliaca Block

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260328003

Enrollment

Registered

2026-03-28

Start date

2024-06-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients indicated for hip arthroplasty Postoperative analgesic efficacy, hip replacement, intermittent fascia iliaca catheter , single-injection fascia iliaca, levobupivacain

Interventions

Fascia iliaca block with catheter placement in the fascia iliaca compartment, administering an initial bolus of 30 mL of 0.25% levobupivacaine, followed by intermittent injections of 15 mL of 0.25% le

Experimental Procedure/Surgery,Experimental Procedure/Surgery

Intermittent bolus via fascia iliaca catheter,single shot fascia iliaca block

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients indicated for hip arthroplasty were required to meet the following criteria to be included in the study. 2. age older than 18 years. 3. physical status classified as ASA I to III. 4. ability to communicate normally and to perform pain assessment using the Visual Analog Scale (VAS) and provision of written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Contraindications to regional anesthesia, including infection at the injection site and coagulation disorders, known allergy to levobupivacaine or paracetamol, history of long-term opioid use or hypersensitivity to opioids, severe hepatic or renal impairment, history of psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
Postoperative pain score (VAS) At rest and during movement at 0, 1, 2, 4, 6, 8, 12 and 24h postoperatively Visual Analog Scale (VAS), 0 to 10,Total morphine consumption Within 24 hours postoperatively Cumulative intravenous morphine dose (mg),Time to first rescue analgesia Postoperative period Time (hours) from the end of surgery to first morphine administration	—

Secondary

Measure	Time frame
Postoperative nausea and vomiting (PONV) Within 24 hours postoperatively Incidence of nausea and/or vomiting,Motor block (Bromage score) At rest and during movement at 0, 1, 2, 4, 6, 8, 12 and 24h postoperatively Modified Bromage Scale ( 0 to 3),Patient satisfaction score 24 hours after surgery 5-point Likert scale (1 very dissatisfied to 5 very satisfied)	—

Countries

Vietnam

Contacts

Public ContactTrinh Tran

Department of Anesthesiology and Critical Care, Emergency and Toxicology

tranttrinh98@gmail.com84357643311

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026